Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion

European Journal of Ophthalmology

Volumn 25, Issue 5, 2015, Pages 454-458

  Caillaux, Violaine ^a   Valtot, Françoise ^b,c   Souied, Eric H ^a   Mimoun, Gérard ^a,c  

^a CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^b SAINT JOSEPH HOSPITAL   (France)

^c Centre de la Rétine de l’Ecole Militaire Ecole Militaire Retina Centre ^*  (France)

Author keywords

Corticosteroids; Intraocular pressure; Intravitreal injection; Macular edema; Retinal vein occlusion; Sustained release dexamethasone implant

Indexed keywords

DEXAMETHASONE; DRUG IMPLANT; GLUCOCORTICOID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; MACULAR EDEMA; MALE; OPHTHALMOLOGICAL IMPLANT; OPHTHALMOLOGY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA VEIN OCCLUSION; RETROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; COMPLICATION; DRUG EFFECTS; DRUG IMPLANT; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MIDDLE AGED; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; RETINAL VEIN OCCLUSION;

ADULT; AGED; AGED, 80 AND OVER; DEXAMETHASONE; DRUG IMPLANTS; FEMALE; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR EDEMA; MALE; MIDDLE AGED; RETINAL VEIN OCCLUSION; RETROSPECTIVE STUDIES; TONOMETRY, OCULAR;

EID: 84940047428     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000585     Document Type: Article

References (14)

1. Rogers S, McIntosh RL, Cheung N, et al; International Eye Disease Consortium. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia. Ophthalmology. 2010;117:313-9.
2. Rehak J, Rehak M. Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities. Curr Eye Res. 2008; 33:111-31.
3. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther. 2008;16:791-9.
4. Haller JA, Bandello F, Belfort R Jr, et al; OZURDEX GENEVA Study Group. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134-46.
5. Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90:999-1003.
6. Goldstein DA, Godfrey DG, Hall A, et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch Ophthalmol. 2007;125:1478-85.
7. Kiddee W, Trope GE, Sheng L, et al. Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol. 2013;58:291-310.
8. Boyer DS, Faber D, Gupta S, et al; Ozurdex CHAMPLAIN Study Group. Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina. 2011; 31:915-23.
9. Haller JA, Dugel P, Weinberg DV, Chou C, Whitcup SM. Evaluation of the safety and performance of an applicator for a novel intravitreal dexamethasone drug delivery system for the treatment of macular edema. Retina. 2009;29:46-51.
10. Haller JA, Kuppermann BD, Blumenkranz MS, et al; Dexamethasone DDS Phase II Study Group. Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema. Arch Ophthalmol. 2010; 128:289-96.
11. Haller JA, Bandello F, Belfort R Jr, et al; Ozurdex GENEVA Study Group. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion twelve-month study results. Ophthalmology. 2011;118: 2453-60.
12. Kim JE, Mantravadi AV, Hur EY, Covert DJ. Short-term intraocular pressure changes immediately after intravitreal injections of anti- vascular endothelial growth factor agents. Am J Ophthalmol. 2008;146:930-4.
13. Clark AF. Basic sciences in clinical glaucoma: steroids, ocular hypertension, and glaucoma. J Glaucoma. 1995;4:354-69.
14. Hayreh SS, Zimmerman MB, Beri M, Podhajsky P. Intraocular pressure abnormalities associated with central and hemicentral retinal vein occlusion. Ophthalmology. 2004;111:133-41.